Jennifer Moses is the founder of G1 Therapeutics. G1 Therapeutics has raised $13M in total funding. Latest round: Series A.
Jennifer Moses serves as the Chief Financial Officer (CFO) of G1 Therapeutics, a biopharmaceutical company focused on oncology treatments. She is responsible for the company's financial operations and investor communications, particularly noted for her role in releasing G1's 2022 financial results.
Full founder directory · Investor directory · Company funding database · Fundraising library